John Kreese, played by the one and only Martin Kove, has been as central to "Cobra Kai" as he was to the original "Karate Kid ...

Read up on the latest Cobra Kai News, Reviews and Features from the team at Collider. Your comment has not been saved Thirty-four years after events of the 1984 All Valley Karate Tournament ...

This may be the end, but we’re not good at goodbyes…because COBRA KAI NEVER DIES! The final episodes of the greatest karate saga of all time arrive on February 13th, 2025, only on Netflix.

Number One on Netflix is a weekly spotlight on whatever is currently the most popular thing on the world’s most popular ...

Part of the management team, soaking it all in, is Joe Moran, who has been with the company since 2019, a year after it launched. The 30-year-old native of California recently had a title change ...

On Netflix, we're excited for a new chapter of The Witcher, plus the last five episodes of Cobra Kai arrive this ... drama arrives on Feb. 13. The animated film The Witcher: Sirens of the Deep ...

Spoilers ahead of Cobra Kai season 6! Thus far, the Karate Kid spin-off series centered on the events of the Sekai Taikai, the karate world championship where Johnny Lawrence, Daniel LaRusso ...

Bengals quarterback Joe Burrow celebrates a Week 17 overtime win over the Denver Broncos that kept Cincinnati's slim playoff hopes alive. Burrow threw for 412 yards and three touchdowns in the ...

How To Train Your Dragon came to theaters just a few months after James Cameron’s Avatar, and this animated film proved that the Titanic director wasn’t the only one who could make stunning 3D ...

Joe Rogan says Trump shattered his health theory "Trump… eats nothing but McDonald's, drinks Diet Cokes, sharp as a tack, 78 years old," said Rogan. "Like, okay, I don't know what to tell you." ...

It affects around 130,000 people in the US, mainly women, with its prevalence on the rise. Symptoms include debilitating fatigue and itching (pruritus), and it can worsen over time if not ...

Gilead Sciences' TROP2-directed drug Trodelvy has missed the target in another clinical trial, this time in urothelial carcinoma, the most common form of bladder cancer. The results of the TROPiCS ...